Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

Humerus Fracture Clinical Trial

Official title:

Low Dose Interscalene and Infraclavicular Block for Humerus Surgery

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT02756156
• Other study ID #: 76263
• Status: Not yet recruiting
• Phase: N/A
• First received: March 15, 2016
• Last updated: April 26, 2016
• Start date: April 2016
• Est. completion date: August 2016

Study information

• Verified date: March 2016
• Source: Kahramanmaras Sutcu Imam University
• Contact: Bora Bilal, Asist. Prof.
• Phone: +903442803245
• Email: bilalbora[@]yahoo.com
• Is FDA regulated: No
• Health authority: Turkey: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Combining interscalene block with infraclavicular block for humerus surgery provides a unique surgical anaesthesia and postoperative analgesia.

Description:

Interscalene block provides effective surgical anaesthesia for shoulder and proximal arm surgery. However, sometimes it can be inadequate for distal arm surgery. Combining infraclavicular block with interscalene block may provide a successful surgical anaesthesia for humerus surgery.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 30
• Est. completion date: August 2016
• Est. primary completion date: August 2016
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients accepting peripheral nerve block technique for humerus surgery

• Unilateral orthopedic humerus surgery

• 18 years of age or older

Exclusion Criteria:

• Patients refused peripheral nerve block

• Non-cooperate patients

• Neuropathy of any etiology in the affected extremity

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Humeral Fractures
• Humerus Fracture

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Kahramanmaras Sutcu Imam University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Success rate of block	A complete sensory loss in distribution of the radial, median, ulnar, musculocutaneous and medial cutaneous nerves of the arm	10 min.- 20 min.	No
Secondary	Technique duration		5 min.	No
Secondary	Number of participants with treatment-related adverse events as assessed by CTCAE v4.0		24 hours	No
Secondary	Complication rate		24 hours	No